How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research bioMerieux Inc in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
253 clearance records and 572 recall records in the covered releases, across 1 source company names and 88 product codes. Dated history runs from Feb 9, 1983 to Nov 4, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 1 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 1 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 1 |
| July 2026 | 1 | 1 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 1 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| DENSICHECK PLUSK093224 · LON | bioMerieux, Inc. | 510(k) | Nov 9, 2009FDA decision date |
| DENSICHEK PLUSK083536 · LON | bioMerieux, Inc. | 510(k) | Sep 11, 2009FDA decision date |
| VITEK 2 GRAM NEGATIVE MEROPENEMK091899 · LON | bioMerieux, Inc. | 510(k) | Aug 14, 2009FDA decision date |
| CHROMID MRSA AGAR, MODEL: REF 43 841K091024 · JSO | bioMerieux, Inc. | 510(k) | Jul 17, 2009FDA decision date |
| VIDAS CA 15-3 ASSAYK080469 · LTK | bioMerieux, Inc. | 510(k) | Jun 22, 2009FDA decision date |
| VITEK 2 GRAM POSITIVE DAPTOMYCINK091126 · LON | bioMerieux, Inc. | 510(k) | Jun 18, 2009FDA decision date |
| VIDAS CA 125 II ASSAYK080561 · LTK | bioMerieux, Inc. | 510(k) | Apr 10, 2009FDA decision date |
| VITEK 2 GRAM NEGATIVE DORIPENEMK082346 · LON | bioMerieux, Inc. | 510(k) | Mar 16, 2009FDA decision date |
| VITEK 2 GRAM POSITIVE ERYTHROMYCIN FOR STREPTOCOCCUS PNEUMONIAEK083383 · LON | bioMerieux, Inc. | 510(k) | Feb 18, 2009FDA decision date |
| VIDAS RUB IGGK080766 · LFX | bioMerieux, Inc. | 510(k) | Dec 23, 2008FDA decision date |
| VIDAS CEA (S) ASSAYK080194 · DHX | bioMerieux, Inc. | 510(k) | Oct 9, 2008FDA decision date |
| VIDAS AFP ASSAYK080017 · LOJ | bioMerieux, Inc. | 510(k) | Sep 26, 2008FDA decision date |
| NUCLISENS EASYQ ENTEROVIRUS SYSTEMK063261 · OAI | bioMerieux, Inc. | 510(k) | Jun 23, 2008FDA decision date |
| VIDAS C. DIFICILE TOXIN A & B (CDAB) ASSAYK080931 · LLH | bioMerieux, Inc. | 510(k) | Jun 11, 2008FDA decision date |
| VITEK 2 GRAM POSITIVE INDUCIBLE CLINDAMYCIN RESISTANCEK080201 · LON | bioMerieux, Inc. | 510(k) | Apr 30, 2008FDA decision date |
| VIDAS NT-PROBNP ASSAY, MODEL: 30 449K073091 · NBC | bioMerieux, Inc. | 510(k) | Feb 29, 2008FDA decision date |
| VITEK 2 GRAM NEGATIVE PIPERACILLIN/TAZOBACTAMK080107 · LON | bioMerieux, Inc. | 510(k) | Feb 28, 2008FDA decision date |
| VITEK 2 GRAM NEGATIVE TRIMETHOPRIM/SULFAMETHOXAZOLEK073406 · LON | bioMerieux, Inc. | 510(k) | Jan 23, 2008FDA decision date |
| bioMerieux, BacT/ALERT FA Culture Bottles, bioMerieux, Inc., Durham, NC 27704Z-0457-2008 · MDB | bioMerieux, Inc. | Recall | Jan 4, 2008FDA classification date |
| VIDAS C. DIFFICILE TOXIN A&B (CDAB) ASSAY, MODEL: 30 118K072138 · LLH | bioMerieux, Inc. | 510(k) | Dec 21, 2007FDA decision date |
| VIDAS TROPONIN I ULTRA (TNIU) ASSAY, MODEL 30 448K063243 · MMI | bioMerieux, Inc. | 510(k) | Dec 14, 2007FDA decision date |
| VITEK 2 GRAM NEGATIVE PIPERACILLINK073083 · LON | bioMerieux, Inc. | 510(k) | Dec 10, 2007FDA decision date |
| VITEK 2 GRAM POSITIVE TIGECYCLINEK072695 · LON | bioMerieux, Inc. | 510(k) | Nov 16, 2007FDA decision date |
| VITEK 2 GRAM POSITIVE VANCOMYCINK072668 · LON | bioMerieux, Inc. | 510(k) | Oct 15, 2007FDA decision date |
| VIDAS B.R.A.H.M.S. PCT ASSAYK071146 · NTM | bioMerieux, Inc. | 510(k) | Oct 11, 2007FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.